During the corresponding time, Waters Corporation recorded a revenue increase by 113.27 % year on year, sequentially revenue grew by 29.83 %. While revenue at the Waters Corporation's corporate clients
Waters's Comment on Sales, Marketing and Customers
The company provides products for research and development, quality assurance, and laboratory applications across various industries. Its offerings are used to detect, identify, monitor, and measure chemical, physical, and biological compositions, as well as to purify compounds. Key markets include drug discovery and development, clinical trial testing, proteomics, nutritional safety analysis, environmental testing, industrial applications, consumer goods, healthcare products, and life science research. After acquiring the Biosciences and Diagnostic Solutions businesses of Becton, Dickinson and Company (BD), the company expanded into life sciences and diagnostics. This expansion includes products for the safe collection and transport of diagnostic specimens, instruments and reagent systems for detecting infectious diseases, healthcare-associated infections, cancers, immunology and cancer research, clinical diagnostics such as flow cytometry instruments and reagents, and multiomics tools. The company operates through four segments: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences.
Waters’s Comment on Sales, Marketing and Customers
The company provides products for research and development, quality assurance, and laboratory applications across various industries. Its offerings are used to detect, identify, monitor, and measure chemical, physical, and biological compositions, as well as to purify compounds. Key markets include drug discovery and development, clinical trial testing, proteomics, nutritional safety analysis, environmental testing, industrial applications, consumer goods, healthcare products, and life science research. After acquiring the Biosciences and Diagnostic Solutions businesses of Becton, Dickinson and Company (BD), the company expanded into life sciences and diagnostics. This expansion includes products for the safe collection and transport of diagnostic specimens, instruments and reagent systems for detecting infectious diseases, healthcare-associated infections, cancers, immunology and cancer research, clinical diagnostics such as flow cytometry instruments and reagents, and multiomics tools. The company operates through four segments: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences.
Sources:
Waters Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Waters Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Waters Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
130.03 %